AMEREN CORP
For the period ended Mar 31, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 5, 2025
AEE$114.02+1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Shareholders’ Equity
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Common Stock | $3 | $3 |
| Other Paid-in Capital: | ||
| Beginning of year | 7,513 | 7,216 |
| Shares issued under the DRPlus and 401(k) plan | 15 | 10 |
| Stock-based compensation activity | (4) | 2 |
| Other paid-in capital, end of period | 7,524 | 7,228 |
| Retained Earnings: | ||
| Beginning of year | 4,604 | 4,136 |
| Net income attributable to Ameren common shareholders | 289 | 261 |
| Dividends on common stock | (191) | (178) |
| Retained earnings, end of period | 4,702 | 4,219 |
| Accumulated Other Comprehensive Loss: | ||
| Derivative financial instruments, beginning of year | 3 | — |
| Change in derivative financial instruments | (4) | — |
| Derivative financial instruments, end of period | (1) | — |
| Deferred retirement benefit costs, beginning of year | (9) | (6) |
| Change in deferred retirement benefit costs | — | (1) |
| Deferred retirement benefit costs, end of period | (9) | (7) |
| Total accumulated other comprehensive loss, end of period | (10) | (7) |
| Total Shareholders’ Equity | $12,219 | $11,443 |
| Noncontrolling Interests: | ||
| Beginning of year | 129 | 129 |
| Net income attributable to noncontrolling interest holders | 1 | 1 |
| Dividends paid to noncontrolling interest holders | (1) | (1) |
| Noncontrolling interests, end of period | 129 | 129 |
| Total Equity | $12,348 | $11,572 |
| Common stock shares outstanding at beginning of year | 269.9 | 266.3 |
| Shares issued under the DRPlus and 401(k) plan | 0.1 | 0.1 |
| Shares issued for stock-based compensation | 0.3 | 0.2 |
| Common stock shares outstanding at end of period | 270.3 | 266.6 |
| Dividends per common share | $0.71 | $0.67 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.